Skip to Content

BD Persist

Dosage form: solution
Ingredients: POVIDONE-IODINE 85mg in 1mL, alcohol 65mg in 1mL
Labeler: Becton Dickinson Infusion Therapy Systems Inc.
NDC Code: 17271-507

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Facts

Active Ingredient

Providone-Iodine 10% (w/w)

Ethyl Alcohol 70% (v/v)




  • for preparation of the skin prior to percutaneous procedure
  • helps reduce bacteria that potentially can cause skin infection
  • does not contribute to skin irritation under an occlusive dressing with repeated applications
  • reduces bacteria with routine site care for up to seven days

  • For external use only
  • contains alcohol which is flammable until dry

Do not use
  • if you are allergic to povidone iodine or ethyl alcohol
  • to treat wounds or burns
  • in eyes, mucus membranes
  • on broken skin
  • with electrocautery procedures

Stop use and ask a doctor if the insertion site becomes

  • red
  • irritated
  • swollen
  • painful
  • infected

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • apply with friction for 30 seconds
  • allow to dry
  • do not blot or wipe away

Inactive ingredients

acrylates copolymer, ethyl alcohol, isopropyl myristate, urea, water

Principal Display Panel – Carton Label

BD Persist
Skin Prep

One Step Application
One Swab Stick


Principal Display Panel – Package Label

BD Persist™ Skin Prep
1 Swab Stick • REF 386401 NDC 17271-507-01

povidone-iodine, alcohol solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:17271-507
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
alcohol (alcohol) alcohol65 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
carbomer copolymer Type A 
ethyl acetate 
isopropyl myristate 
#Item CodePackage Description
1NDC:17271-507-0150 PACKAGE (50 PACKAGE) in 1 CARTON
12 mL in 1 PACKAGE
2NDC:17271-507-0225 PACKAGE (25 PACKAGE) in 1 CARTON
27 mL in 1 PACKAGE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart333A02/21/1996
Labeler - Becton Dickinson Infusion Therapy Systems Inc. (124987988)
Becton Dickinson Infusion Therapy Systems Inc.124987988MANUFACTURE(17271-507)

Becton Dickinson Infusion Therapy Systems Inc.

Medically reviewed on Sep 13, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.